Margolis, D. A., Gonzalez-Garcia, J., Stellbrink, H., Eron, J. J., Yazdanpanah, Y., Podzamczer, D., Lutz, T., Angel, J. B., Richmond, G. J., Clotet, B., Gutierrez, F., Sloan, L., Clair, M. S., Murray, M., Ford, S. L., Mrus, J., Patel, P., Crauwels, H., Griffith, S. K., Sutton, K. C., Dorey, D., Smith, K. Y., Williams, P. E., & Spreen, W. R. (2017). long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial. Lancet, 390(10101), 1499–1510. http://access.bl.uk/ark:/81055/vdc_100066539729.0x000051